Alma Capital is an independent fund management company that partners with investment managers across strategies in listed and private asset classes. The company performs regulatory, compliance, risk, and operational functions for funds and provides distribution services to European institutional investors. This description is self-described.

Alma Capital

Alma Capital Partners provides a personalized approach to business transitions for owners seeking succession plans. It aims to invest in single companies in North America with established track records and growth potential, partnering with management to unlock barriers to growth. Self-described as an experienced team of entrepreneurs and investors.

Alma Capital Partners

Apex Group provides financial solutions including fund administration, custody services, and regulatory compliance. The services are self-described as a single-source solution for asset managers and corporations.

Apex Group

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

Metric
Company Name	Alma Capital	Alma Capital Partners	Apex Group	Otsuka Holdings Co., Ltd.
Symbol				4.58K
MSH ID	COM:ALMACAPITAL	COM:ALMACAPA	COM:APEXGROUP	COM:OTSUKA
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Financial Services & Finance	Financial Services & Finance	Financial Services & Finance	Healthcare
Industry	Investment Management	Investment Management	Financial Services	Drug Manufacturers - General
Country	LU	US	US	JP
Stage
Employee Count				34.39K
Website	almacapital.com	almacapa.com	apexgroup.com	otsuka.com
LinkedIn
Founders

Metric
Market Cap		26.07B
Enterprise Value
Monthly Web Traffic	67	46.07K
Web Traffic Growth	-0.93	1.45
Valuation
Raised Capital

Metric
Revenue				13.46B
Revenue (LTM)
Revenue (NTM)
Gross Profit				9.39B
EBITDA				2.60B
Operating Income				1.95B
Net Income				811.10M
EPS				1.49
Diluted EPS				1.49
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.71
Operating Profit Margin				0.15
EBITDA Margin				0.19
Net Profit Margin				0.07
Return on Equity				0.06
Return on Assets				0.04
Return on Capital Employed				0.11

ALMA

COM:ALMACAPITAL

Alma Capital

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				16.87
P/B Ratio				1.25
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				2.26
EV Multiple				11.34

Metric
Days Sales Outstanding				94.09
Days Payables Outstanding				115.26
Days Inventory Outstanding				169.37
Operating Cycle				259.01
Cash Conversion Cycle				136.71
Asset Turnover				0.61

Metric
Operating Cash Flow				1.89B
Free Cash Flow				1.12B
Cash Flow to Debt				1.80
Operating Cash Flow/Sales				0.14
Free Cash Flow Yield				0.04

Metric
Cash & Equivalents				3.42B
Accounts Receivable				-212.10M
Inventory				1.66B
Goodwill				2.53B
Debt to Capitalization				0.07
Debt to Assets				0.05
Current Ratio				2.14
Quick Ratio				1.66

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue				0.15
SG&A to Revenue				0.40